The Heart-Access Medical-B (02160) establishes a strategic committee and a commercialization committee.

Great Wall Securities News APP reported that Heartland Medical-B (02160) announced that effective from December 15, 2025: Non-executive director and chairman of the board, Mr. Chen Guoming, has been appointed as a member of the audit committee and will no longer serve as a member of the remuneration committee and chairman of the nomination committee. Independent non-executive director Dr. Hu Bingshan has been appointed as chairman of the nomination committee and as a member of the remuneration committee, and will no longer serve as a member of the audit committee. Non-executive director Dr. Brian Chang has been appointed as a member of the nomination committee.